Institut Jules Bordet is a specialized general hospital and research institute of the Université libre de Bruxelles which specializes in oncology. It is located in Brussels, Belgium.

During the past decade, Institut Jules Bordet conducted 224 clinical trials. In the 10-year time frame, 224 clinical trials started and 87 clinical trials were completed, i.e. on average, 38.8% percent of trials that started reached the finish line to date. In the past 5 years, 82 clinical trials started and 61 clinical trials were completed. i.e. 74.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Jules Bordet" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 86 trials, followed by "Jules Bordet Institute" with 61 trials sponsored, "Hoffmann-La Roche" with 21 trials sponsored, "The Lymphoma Academic Research Organisation" with 15 trials sponsored and "Pfizer" with 15 trials sponsored. Other sponsors include 242 different institutions and companies that sponsored additional 151 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jules Bordet" #1 collaborator was "Breast International Group" with 12 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 9 trials as a collaborator, "Jules Bordet Institute" with 9 trials as a collaborator, "Hoffmann-La Roche" with 8 trials as a collaborator and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 5 trials as a collaborator. Other collaborators include 261 different institutions and companies that were collaborators in the rest 200 trials.

According to Clinical.Site data, the most researched conditions in "Institut Jules Bordet" are "Breast Cancer" (66 trials), "Colorectal Cancer" (17 trials), "Leukemia" (15 trials), "Lymphoma" (14 trials) and "Multiple Myeloma" (14 trials). Many other conditions were trialed in "Institut Jules Bordet" in a lesser frequency.

Most popular intervention types in "Institut Jules Bordet" are "Drug" (369 trials), "Biological" (57 trials), "Procedure" (51 trials), "Radiation" (35 trials) and "Other" (33 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "radiation therapy" (22 trials), "cisplatin" (18 trials), "fluorouracil" (15 trials) and "Paclitaxel" (14 trials). Other intervention names were less common.

The vast majority of trials in "Institut Jules Bordet" are 336 trials for "All" genders, 91 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 125 active trials in "Institut Jules Bordet". 1 are not yet recruiting, 62 are recruiting, 61 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 224 completed trials in Institut Jules Bordet, 2 suspended trials, and 46 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Jules Bordet, 98 "Phase 1" clinical trials were conducted, 182 "Phase 2" clinical trials and 164 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 23 trials that are defined as “Not Applicable".

Institut Jules Bordet has several departments that took part in Clinical trials: "Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet" - 11 trials, "Institut Jules Bordet - Oncologie Médicale" - 6 trials, "Institut Jules Bordet Unite du Chimiotherapie" - 3 trials, "Institut Jules Bordet Clinical Trials Conduct Unit" - 2 trials, "Institut Jules Bordet - Medical Oncology" - 2 trials